Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
98 studies found for:    Acetylcholinesterase
Show Display Options
Rank Status Study
1 Completed Acetylcholinesterase in Postoperative Delirium
Condition: Delirium
Intervention:
2 Completed A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: EHT 0202 etazolate;   Drug: Placebo
3 Unknown  Acetylcholinesterase Inhibition and Orthostatic Hypotension in SC I
Condition: Hypotension, Postural
Intervention: Drug: Pyridostigmine Bromide
4 Recruiting Treatment With Acetyl-Choline Esterase Inhibitors in Children With Autism Spectrum Disorders
Condition: Autism
Interventions: Drug: Acetyl-Choline Esterase Inhibitors and Choline supplements;   Drug: Indistinguishable placebo tablets, matching both donepezil and choline
5 Active, not recruiting Lu AE58054 in Patients With Mild to Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
Condition: Alzheimer's Disease
Interventions: Drug: Placebo;   Drug: Lu AE58054
6 Completed Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
Condition: Alzheimer's Disease
Interventions: Drug: ABT-354;   Drug: Placebo
7 Terminated
Has Results
Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237;   Drug: Placebo
8 Suspended Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Donepezil
9 Completed Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
Condition: Alzheimer's Disease
Interventions: Drug: ABT-126;   Drug: placebo
10 Terminated Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
Condition: Alzheimer's Disease
Interventions: Drug: ABT-957;   Other: Placebo for ABT-957
11 Recruiting A Pilot Study of Pyridostigmine in Pompe Disease
Condition: Pompe Disease
Intervention: Drug: Pyridostigmine Bromide
12 Completed Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke
Condition: Cerebrovascular Accident
Interventions: Drug: Galantamine;   Drug: Donepezil
13 Completed Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor
Conditions: Alzheimer's Disease;   Sleep Disorder
Interventions: Drug: Circadin;   Drug: Placebo
14 Completed A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ABT-126;   Drug: Placebo
15 Terminated Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: ABT-126
16 Terminated Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Drug: EVP-6124;   Drug: Placebo
17 Terminated Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Drug: EVP-6124;   Drug: Placebo
18 Withdrawn Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
Conditions: Alzheimer's Disease;   Dementia;   Cognition
Intervention: Drug: EVP-6124
19 Terminated Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
Condition: Alzheimer's Disease
Intervention: Drug: Rosiglitazone XR
20 Completed Rivastigmine in the Management of Delirium
Condition: Delirium
Interventions: Drug: Rivastigmine transdermal patch;   Drug: placebo patch

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.